|
1 Binkert F, Mutter M, Schinzel A. Impact of prenatal diagnosis on the prevalence of live births with Down's syndrome in the eastern half of Switzerland 1980-1996[J]. Swiss Med Wkly, 2002, 132(33-34): 478-484.
|
|
2 Zhu BS, Jiao CS, Zhu S, et al. A study on the incidence of Down's syndrome an the interference by prenatal screening[J/CD]. Chin J Obstet Gynecol Pediatr (Electron Ed), 2005, 1(1)：20-23.[朱宝生，焦存仙，朱姝，等.唐氏综合征发生率及其受产前筛查干预的研究[J/CD].中华妇幼临床医学杂志：电子版，2005, 1(1)：20-23.]
|
|
3 Bian XM, Liu JT, Qi QW, et al. Second trimester maternal serum screening for Down's syndrome in mainland China: A multi-center prospective study[J]. Chin J Obstet Gynecol, 2008, 43(11): 805-809.[边旭明，刘俊涛，戚庆炜，等.对孕中期妇女行血清学二联指标筛查胎儿唐氏综合征的多中心前瞻性研究[J].中华妇产科杂志，2008, 43(11): 805-809.]
|
|
4 Noble J. Natural history of Down's syndrome: A brief review for those involved in antenatal screening[J]. J Med Screen, 1998, 5(4): 172-177.
|
|
5 Carr J. Six weeks to twenty-one years old: A longitudinal study of children with Down's syndrome and their families. Third Jack Tizard memorial lecture[J]. J Child Psychol Psychiatry, 1988, 29(4): 407-431.
|
|
6 Wang B, Chen YY, Shi Q, et al. The Economic Burden of Down's Syndrome in China[J]. Chin Health Econ, 2006, 25(3): 24-26.[王斌，陈英耀，石琦，等.我国唐氏综合征的疾病经济负担研究[J].中国卫生经济，2006, 25(3): 24-26.]
|
|
7 Meyers C, Adam R, Dungan J, et al. Aneuploidy in twin gestations: When is maternal age advanced[J]? Obstet Gynecol, 1997, 89: 248-251.
|
|
8 ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No.77: Screening for fetal chromosomal abnormalities[J]. Obstet Gynecol, 2007, 109(1): 217-227.
|
|
9 Resta GR. Changing demographics of advanced maternal age (AMA) and the impact on the predicted incidence of Down's syndrome in the United States: Implications for prenatal screening and genetic counseling[J]. Am J Med Genet, Part A, 2005, 133A(1): 31-36.
|
|
10 Yin YF, Zhu BS, Su J, et al. Screening efficiency triple screening for Down's syndrome in pregnancy associated with the two screening[J]. Maternal Child Health Care China, 2009, 24：3130-3133.[银益飞，朱宝生，苏洁，等．中孕期唐氏综合征三联筛查与二联筛查的筛查效率．中国妇幼保健，2009，24：3130-3133.]
|
|
11 Driscoll DA. American college of medical genetics policy statement. Second trimester maternal serum screening for fetal open neural tube defects and aneuploidy[J]. Genet Med, 2004, 6: 540-541.
|
|
12 Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down's syndrome[J]. N Engl J Med, 2005, 353(19): 2001-2011.
|
|
13 Knight GJ, Palomaki GE, Neveux LM, et al. Integrated serum screening for screening for Down's Syndrome in primary obstetric practice[J]. Prenat Diagn, 2005, 25(12): 1162-1167.
|
|
14 Cuckle HS, Arbuzova S. Multimarker maternal serum screening for chromosomal abnormalities. In: Millunsky A, ed. Genetic disorders and the fetus: Diagnosis, prevention, and treatment[M]. 5 th ed. Baltimore, MD: The Johns-Hopkins University Press, 2004, 795-835，836-900.
|
|
15 Nicholaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities[J]. Am J Obstet Gynecol, 2004, 191(1): 45-67.
|
|
16 Benn P, Weight D, Cuckle H. Practical strategies in contingent sequential screening for Down syndrome[J]. Prenat Diag, 2005, 25: 645-652.
|
|
17 Wapner R, Thom E, Simpson JL, et al. First-Trimester Screening for Trisomies 21 and 18[J]. N Engl J Med, 2003, 349: 1405-1413.
|
|
18 Wald NJ, Rodeck C, Hackshaw AK, et al. SURUSS in perspective[J]. BJOG, 2004, 111(6): 521-531.
|
|
19 Avgidou K, Papageorghiou A, Bindra R, et al. Prospective first-trimester screening for trisomy 21 in 30，564 pregnancies[J]. AJOG, 2005, 192: 1761-1767.
|